Vice President of Portfolio & Programs

Danaher•Deer Park, TX

1d•$310,000 - $350,000•Onsite

About The Position

Bring more to life. Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? At Leica Biosystems, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact. You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life. At Leica Biosystems, we’re not just shaping the future of cancer diagnostics — we’re transforming lives. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is the driving force behind everything we do. As a global leader with the most comprehensive portfolio spanning from biopsy to diagnosis, we empower clinicians with innovative, reliable solutions so they can give patients timely, accurate answers when they need them most. When you join Leica Biosystems, you’re not just taking a job; you’re becoming part of a passionate team that knows every moment matters when it comes to cancer. You’ll help develop diagnostic solutions that turn anxiety into answers, and aid the acceleration of next-generation, life-changing therapies. Surrounded by a diverse and collaborative global community, you’ll be inspired each day to stretch, grow, and make an impact. Learn about the Danaher Business System which makes everything possible. Lead the Future of Precision Diagnostics Leica Biosystems is seeking a visionary and results-driven Vice President of Portfolio & Programs to join the leadership team of our Advanced Staining Reagents (ASR) Business Unit. This is a mission-critical role at the intersection of strategy, innovation, and execution; designed for a senior thought leader who can shape the long-term product portfolio, drive strategic program excellence, and deliver sustained revenue growth. As the VP, you will architect the 3- to 10-year roadmap for our diagnostics portfolio, define and prioritize investment areas, ensure the timely delivery of high-impact solutions, and work closely with commercial and cross-functional leaders to translate strategy into market success. This role also takes direct ownership of key strategic programs and partnership opportunities that will expand our clinical impact, enhance health economic outcomes, and drive share gains in a rapidly evolving global market. You’ll operate with high visibility and influence—using deep market insight, competitive intelligence, and customer engagement to guide smart, high-ROI decisions that elevate Leica’s leadership in digital pathology and precision oncology. Preferred locations: Onsite at our Deer Park, IL (USA). If you thrive in a dynamic, high-performing environment where innovation meets execution—and you’re ready to make an enterprise-wide impact—this is your opportunity to lead at the forefront of cancer diagnostics.

Requirements

Master’s degree required; MBA or advanced scientific/technical degree preferred or 15+ years of progressive experience in diagnostics, medical devices, biopharma, or related life sciences sectors.
Proven leadership in portfolio strategy, product lifecycle management, or general management roles; experience in a top-tier consulting firm or strategic/BD leadership strongly preferred.
Track record of delivering results in matrixed global organizations and navigating cross-functional execution across R&D, commercial, and operations.
Strong strategic thinking, data-driven decision-making, and the ability to distill complex information into clear, actionable insights.
Demonstrated ability to lead, develop, and inspire high-performing teams across geographies and disciplines.
Experience operating in a global context, with comfort working across cultures, time zones, and hybrid work environments.
Must be able to travel approximately 30% of the time; overnight travel will be required.

Responsibilities

Shape the Future of Oncology Diagnostics. Define and maintain a multi-year strategic portfolio roadmap based on clinical utility, health economic outcomes, unmet market needs, and scientific innovation. Drive portfolio prioritization that fuels revenue growth and market leadership.
Drive Program Excellence. Oversee all cross-functional program execution, leveraging new efficiency tools/AI as needed, to ensure the timely delivery of differentiated products. Partner with R&D, Operations, Regulatory, and Commercial to optimize program velocity, ROI, and value creation. Deliver consistent year-over-year double-digit revenue growth across key business segments.
Lead High-Impact Strategic Initiatives. Personally lead critical programs that align with the business unit’s growth vision—ranging from new product introductions to transformative partnerships and platform extensions (e.g., AI-driven diagnostics, novel biomarkers, multiplexing, spatial, etc.).
Enable Strategic Decision-Making. Build strategic frameworks grounded in data and insights from epidemiology, biopharma pipelines, customer feedback, reimbursement trends, and market intelligence. Influence C-level decision-making through crisp storytelling and evidence-based business cases.
Accelerate Innovation Through Collaboration. Engage with top academic institutions, clinical KOLs, digital pathology thought leaders, and biopharma partners to co-develop cutting-edge diagnostic solutions and expand clinical/computational content offerings on our digital pathology platform.
Own Commercial Performance. Lead BU-direct business with full revenue accountability (~$15M) and an ambition to scale through both organic growth and strategic partnerships.